Skip to main content
Top
Published in: Population Health Metrics 1/2016

Open Access 01-12-2016 | Research

Changes in life expectancy 1950–2010: contributions from age- and disease-specific mortality in selected countries

Authors: Jochen Klenk, Ulrich Keil, Andrea Jaensch, Marcus C. Christiansen, Gabriele Nagel

Published in: Population Health Metrics | Issue 1/2016

Login to get access

Abstract

Background

Changes of life expectancy over time serve as an interesting public health indicator for medical, social and economic developments within populations. The aim of this study was to quantify changes of life expectancy between 1950 and 2010 and relate these to main causes of death.

Methods

Pollard’s actuarial method of decomposing life expectancy was applied to compare the contributions of different age- and disease-groups on life expectancy in 5-year intervals.

Results

From the 1960 to 70s on, declines in cardiovascular disease (CVD) mortality play an increasing role in improving life expectancy in many developed countries. During the past decades gains in life expectancy in these countries were mainly observed in age groups ≥65 years. A further consistent pattern was that life expectancy increases were stronger in men than in women, although life expectancy is still higher in women. In Japan, an accelerated epidemiologic transition in causes of death was found, with the highest increases between 1950 and 1955. Short-term declines and subsequent gains in life expectancy were observed in Eastern Europe and the former states of the Union of Soviet Socialist Republics (USSR), reflecting the changes of the political system.

Conclusions

Changes of life years estimated with the decomposing method can be directly interpreted and may therefore be useful in public health communication. The development within specific countries is highly sensitive to changes in the political, social and public health environment.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Ikeda N, Saito E, Kondo N, Inoue M, Ikeda S, Satoh T, Wada K, Stickley A, Katanoda K, Mizoue T, Noda M, Iso H, Fujino Y, Sobue T, Tsugane S, Naghavi M, Ezzati M, Shibuya K. What has made the population of Japan healthy? Lancet. 2011;378:1094–105.CrossRefPubMed Ikeda N, Saito E, Kondo N, Inoue M, Ikeda S, Satoh T, Wada K, Stickley A, Katanoda K, Mizoue T, Noda M, Iso H, Fujino Y, Sobue T, Tsugane S, Naghavi M, Ezzati M, Shibuya K. What has made the population of Japan healthy? Lancet. 2011;378:1094–105.CrossRefPubMed
3.
go back to reference Olshansky SJ, Ault AB. The fourth stage of the epidemiologic transition: the age of delayed degenerative diseases. Milbank Q. 1986;64:355–91.CrossRefPubMed Olshansky SJ, Ault AB. The fourth stage of the epidemiologic transition: the age of delayed degenerative diseases. Milbank Q. 1986;64:355–91.CrossRefPubMed
5.
go back to reference Houweling TA, Kunst AE, Mackenbach JP. World Health Report 2000: inequality index and socioeconomic inequalities in mortality. Lancet. 2001;357:1671–2.CrossRefPubMed Houweling TA, Kunst AE, Mackenbach JP. World Health Report 2000: inequality index and socioeconomic inequalities in mortality. Lancet. 2001;357:1671–2.CrossRefPubMed
6.
go back to reference Pollard JH. On the decomposition of changes in expectation of life and differentials in life expectancy. Demography. 1988;25:265–76.CrossRefPubMed Pollard JH. On the decomposition of changes in expectation of life and differentials in life expectancy. Demography. 1988;25:265–76.CrossRefPubMed
8.
go back to reference Mathers CD, Fat DM, Inoue M, Rao C, Lopez AD. Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ. 2005;83:171–7.PubMedPubMedCentral Mathers CD, Fat DM, Inoue M, Rao C, Lopez AD. Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ. 2005;83:171–7.PubMedPubMedCentral
9.
go back to reference Pollard JH. The expectation of life and its relationship to mortality. J Inst Actuaries. 1982;109:225–40.CrossRef Pollard JH. The expectation of life and its relationship to mortality. J Inst Actuaries. 1982;109:225–40.CrossRef
10.
go back to reference Rothman KJ, Greenland S. Modern epidemiology. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 1998. Rothman KJ, Greenland S. Modern epidemiology. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 1998.
13.
go back to reference Lawlor DA, Ebrahim S, Davey Smith G. Sex matters: secular and geographical trends in sex differences in coronary heart disease mortality. BMJ. 2001;323:541–5.CrossRefPubMedPubMedCentral Lawlor DA, Ebrahim S, Davey Smith G. Sex matters: secular and geographical trends in sex differences in coronary heart disease mortality. BMJ. 2001;323:541–5.CrossRefPubMedPubMedCentral
14.
go back to reference Waldron I. Sex differences in human mortality: the role of genetic factors. Soc Sci Med. 1983;17:321–33.CrossRefPubMed Waldron I. Sex differences in human mortality: the role of genetic factors. Soc Sci Med. 1983;17:321–33.CrossRefPubMed
15.
16.
17.
go back to reference Klenk J, Nagel G, Ulmer H, Strasak A, Concin H, Diem G, Rapp K. Body mass index and mortality: results of a cohort of 184,697 adults in Austria. Eur J Epidemiol. 2009;24:83–91.CrossRefPubMed Klenk J, Nagel G, Ulmer H, Strasak A, Concin H, Diem G, Rapp K. Body mass index and mortality: results of a cohort of 184,697 adults in Austria. Eur J Epidemiol. 2009;24:83–91.CrossRefPubMed
18.
go back to reference Lopez AD. The evolution of the Global Burden of Disease framework for disease, injury and risk factor quantification: developing the evidence base for national, regional and global public health action. Glob Health. 2005;1:5.CrossRef Lopez AD. The evolution of the Global Burden of Disease framework for disease, injury and risk factor quantification: developing the evidence base for national, regional and global public health action. Glob Health. 2005;1:5.CrossRef
19.
go back to reference Beaglehole R, Bonita R, Alleyne G, Horton R, Li L, Lincoln P, Mbanya JC, McKee M, Moodie R, Nishtar S, Piot P, Reddy KS, Stuckler D. UN high-level meeting on non-communicable diseases: addressing four questions. Lancet. 2011;378:449–55.CrossRefPubMed Beaglehole R, Bonita R, Alleyne G, Horton R, Li L, Lincoln P, Mbanya JC, McKee M, Moodie R, Nishtar S, Piot P, Reddy KS, Stuckler D. UN high-level meeting on non-communicable diseases: addressing four questions. Lancet. 2011;378:449–55.CrossRefPubMed
20.
go back to reference WHO. World Health Statistics 2011. Geneva: World Health Organization; 2011. WHO. World Health Statistics 2011. Geneva: World Health Organization; 2011.
23.
go back to reference Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997;349:1269–76.CrossRefPubMed Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997;349:1269–76.CrossRefPubMed
24.
go back to reference Bonneux LG, Huisman CC, de Beer JA. Mortality in 272 European regions, 2002–2004. An update. Eur J Epidemiol. 2010;25:77–85.CrossRefPubMed Bonneux LG, Huisman CC, de Beer JA. Mortality in 272 European regions, 2002–2004. An update. Eur J Epidemiol. 2010;25:77–85.CrossRefPubMed
25.
go back to reference Helis E, Augustincic L, Steiner S, Chen L, Turton P, Fodor JG. Time trends in cardiovascular and all-cause mortality in the “old” and “new” European Union countries. Eur J Cardiovasc Prev Rehabil. 2011;18:347–59.CrossRefPubMed Helis E, Augustincic L, Steiner S, Chen L, Turton P, Fodor JG. Time trends in cardiovascular and all-cause mortality in the “old” and “new” European Union countries. Eur J Cardiovasc Prev Rehabil. 2011;18:347–59.CrossRefPubMed
26.
go back to reference Finch CE, Crimmins EM. Inflammatory exposure and historical changes in human life-spans. Science. 2004;305:1736–9.CrossRefPubMed Finch CE, Crimmins EM. Inflammatory exposure and historical changes in human life-spans. Science. 2004;305:1736–9.CrossRefPubMed
27.
go back to reference Notzon FC, Komarov YM, Ermakov SP, Sempos CT, Marks JS, Sempos EV. Causes of declining life expectancy in Russia. JAMA. 1998;279:793–800.CrossRefPubMed Notzon FC, Komarov YM, Ermakov SP, Sempos CT, Marks JS, Sempos EV. Causes of declining life expectancy in Russia. JAMA. 1998;279:793–800.CrossRefPubMed
28.
go back to reference Klenk J, Rapp K, Büchele G, Keil U, Weiland SK. Increasing life expectancy in Germany: quantitative contributions from changes in age- and disease-specific mortality. Eur J Public Health. 2007;17:587–92.CrossRefPubMed Klenk J, Rapp K, Büchele G, Keil U, Weiland SK. Increasing life expectancy in Germany: quantitative contributions from changes in age- and disease-specific mortality. Eur J Public Health. 2007;17:587–92.CrossRefPubMed
30.
go back to reference Di Cesare M, Khang Y-H, Asaria P, Blakely T, Cowan MJ, Farzadfar F, Guerrero R, Ikeda N, Kyobutungi C, Msyamboza KP, Oum S, Lynch JW, Marmot MG, Ezzati M. Inequalities in non-communicable diseases and effective responses. Lancet. 2013;381:585–97.CrossRefPubMed Di Cesare M, Khang Y-H, Asaria P, Blakely T, Cowan MJ, Farzadfar F, Guerrero R, Ikeda N, Kyobutungi C, Msyamboza KP, Oum S, Lynch JW, Marmot MG, Ezzati M. Inequalities in non-communicable diseases and effective responses. Lancet. 2013;381:585–97.CrossRefPubMed
31.
go back to reference Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, Baugh V, Bekedam H, Billo N, Casswell S, Cecchini M, Colagiuri R, Colagiuri S, Collins T, Ebrahim S, Engelgau M, Galea G, Gaziano T, Geneau R, Haines A, Hospedales J, Jha P, Keeling A, Leeder S, Lincoln P, McKee M, Mackay J, Magnusson R, Moodie R, Mwatsama M, et al. Priority actions for the non-communicable disease crisis. Lancet. 2011;377:1438–47.CrossRefPubMed Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, Baugh V, Bekedam H, Billo N, Casswell S, Cecchini M, Colagiuri R, Colagiuri S, Collins T, Ebrahim S, Engelgau M, Galea G, Gaziano T, Geneau R, Haines A, Hospedales J, Jha P, Keeling A, Leeder S, Lincoln P, McKee M, Mackay J, Magnusson R, Moodie R, Mwatsama M, et al. Priority actions for the non-communicable disease crisis. Lancet. 2011;377:1438–47.CrossRefPubMed
32.
go back to reference Ezzati M, Riboli E. Can noncommunicable diseases be prevented? Lessons from studies of populations and individuals. Science. 2012;337:1482–7.CrossRefPubMed Ezzati M, Riboli E. Can noncommunicable diseases be prevented? Lessons from studies of populations and individuals. Science. 2012;337:1482–7.CrossRefPubMed
33.
go back to reference Alleyne G, Binagwaho A, Haines A, Jahan S, Nugent R, Rojhani A, Stuckler D. Embedding non-communicable diseases in the post-2015 development agenda. Lancet. 2013;381:566–74.CrossRefPubMed Alleyne G, Binagwaho A, Haines A, Jahan S, Nugent R, Rojhani A, Stuckler D. Embedding non-communicable diseases in the post-2015 development agenda. Lancet. 2013;381:566–74.CrossRefPubMed
34.
go back to reference Bonita R, Magnusson R, Bovet P, Zhao D, Malta DC, Geneau R, Suh I, Thankappan KR, McKee M, Hospedales J, de Courten M, Capewell S, Beaglehole R. Country actions to meet UN commitments on non-communicable diseases: a stepwise approach. Lancet. 2013;381:575–84.CrossRefPubMed Bonita R, Magnusson R, Bovet P, Zhao D, Malta DC, Geneau R, Suh I, Thankappan KR, McKee M, Hospedales J, de Courten M, Capewell S, Beaglehole R. Country actions to meet UN commitments on non-communicable diseases: a stepwise approach. Lancet. 2013;381:575–84.CrossRefPubMed
Metadata
Title
Changes in life expectancy 1950–2010: contributions from age- and disease-specific mortality in selected countries
Authors
Jochen Klenk
Ulrich Keil
Andrea Jaensch
Marcus C. Christiansen
Gabriele Nagel
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Population Health Metrics / Issue 1/2016
Electronic ISSN: 1478-7954
DOI
https://doi.org/10.1186/s12963-016-0089-x

Other articles of this Issue 1/2016

Population Health Metrics 1/2016 Go to the issue